These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12555471)

  • 1. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.
    Quyyumi AA
    Am J Med; 1998 Jul; 105(1A):32S-39S. PubMed ID: 9707266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular endothelium--function, disorders and clinical modification probes].
    Leśniak W; Kolasińska-Kloch W; Kieć B
    Folia Med Cracov; 2001; 42(1-2):5-14. PubMed ID: 11712325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and the endothelium.
    Hsueh WA; Lyon CJ; Quiñones MJ
    Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 10. The proinflammatory and hypercoagulable state of diabetes mellitus.
    Aras R; Sowers JR; Arora R
    Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial function in high risk cardiovascular patients].
    Káli A; Jánosi A
    Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J
    Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial wall: a new pharmacological and therapeutic target?].
    Laurent S; Vanhoutte P; Cavero I; Chabrier PE; Dupuis B; Elghozi JL; Hamon G; Janiak P; Juillet Y; Kher A
    Therapie; 1995; 50(4):387-98. PubMed ID: 7482394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitors and endothelial dysfunction.
    Carretaro OA
    Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endothelial dysfunction and its clinical significance (new trend in cardiology)].
    Kolomoets NM
    Voen Med Zh; 2001 May; 322(5):29-35, 96. PubMed ID: 11550327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction: clinical strategies for treating oxidant stress.
    Fenster BE; Tsao PS; Rockson SG
    Am Heart J; 2003 Aug; 146(2):218-26. PubMed ID: 12891188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction: pathophysiology, diagnosis and prognosis].
    Münzel T
    Dtsch Med Wochenschr; 2008 Nov; 133(47):2465-70. PubMed ID: 19006047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
    Bellien J; Joannides R; Richard V; Thuillez C
    Pharmacol Ther; 2011 Jul; 131(1):1-17. PubMed ID: 21514320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients.
    Tezcan H; Yavuz D; Toprak A; Akpinar I; Koç M; Deyneli O; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):119-23. PubMed ID: 12806595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
    Vijayaraghavan K; Deedwania PC
    Cardiol Clin; 2005 May; 23(2):165-83. PubMed ID: 15694745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.